HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Deliberate self-cutting — Clinical Guidelines

Overview

Deliberate self-cutting, often associated with suicidal ideation, is a form of non-suicidal self-injury (NSSI) frequently observed in adolescents and young adults, impacting mental health and necessitating careful clinical management 1 2 3 4.

Diagnosis

Clinical Presentation: Presence of recurrent self-inflicted injuries primarily through cutting 1 2.

Risk Factors: History of psychiatric disorders, particularly depression and anxiety; exposure to trauma; and certain medications 1 2 5.

Assessment Tools: Use standardized scales like the Columbia-Suicide Severity Rating Scale (C-SSRS) for severity assessment 12.

Screening: Routine screening in high-risk populations, especially adolescents and those with mental health disorders 1 3 4.

Management

First-Line Treatments:

- Psychotherapy: Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT) 1 2 4. - Medication: Selective Serotonin Reuptake Inhibitors (SSRIs) for comorbid depression 1 2 5.

Adjunctive Treatments:

- Emergency Interventions: Stabilization and psychiatric evaluation in ED settings 1 4. - Ketamine: For acute suicidal ideation, though evidence is emerging and requires further study 7.

Special Populations

Pediatrics: Increased vigilance in K-12 populations; link to drug-related suicidal ideation 1 2.

Comorbidities: Polypharmacy, especially involving opioids and psychotropics, associated with higher risk of suicidal ideation 5.

Elderly: Limited specific data; focus on comprehensive psychiatric evaluation and management of chronic conditions 1 3.

Key Recommendations

Routinely screen adolescents and young adults for suicidal ideation and self-injurious behaviors using validated tools (Evidence: Moderate 1 3 4).

Consider CBT and DBT as primary psychotherapeutic interventions for deliberate self-cutting (Evidence: Moderate 1 2 4).

Evaluate and manage polypharmacy, particularly involving psychotropic medications, due to increased risk of suicidal ideation (Evidence: Moderate 5).

Provide immediate psychiatric evaluation and stabilization in emergency settings for acute cases (Evidence: Moderate 1 4).

Pharmacists should actively identify and manage medications linked to suicidal ideation and self-injurious behavior (Evidence: Moderate 8).

References

1 Ju Y, Liu Y, Tan L, Su L. Drug-related suicidal ideation in the K-12 population: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS) database. Journal of psychiatric research 2025. link 2 Xie WL, Xiang DC, Li YY, Ge ML, Deng AP. An exploratory study evaluating the 20 medications most commonly associated with suicidal ideation and self-injurious behavior in the FAERS database. BMC pharmacology & toxicology 2025. link 3 Farooq S, Tunmore J, Wajid Ali M, Ayub M. Suicide, self-harm and suicidal ideation during COVID-19: A systematic review. Psychiatry research 2021. link 4 Lachal J, Grandclerc S, Spodenkiewicz M, Moro MR. [Methods to improve suicidal adolescents' compliance to care after emergency discharge: A literature review]. L'Encephale 2018. link 5 Eide RP, Stahlman S. Polypharmacy involving opioid, psychotropic, and central nervous system depressant medications, period prevalence and association with suicidal ideation, active component, U.S. Armed Forces, 2016. MSMR 2018. link 6 Chin WS, Guo YL, Liao SC, Lin KH, Kuo CY, Chen CC et al.. Suicidality 6 Years After Occupational Injury. The Journal of clinical psychiatry 2018. link 7 Bigman D, Kunaparaju S, Bobrin B. Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed cannabinoids. BMJ case reports 2017. link 8 Lavigne JE. Suicidal ideation and behavior as adverse events of prescribed medications: An update for pharmacists. Journal of the American Pharmacists Association : JAPhA 2016. link 9 Horwitz SM, Heinberg LJ, Storfer-Isser A, Barnes DH, Smith M, Kapur R et al.. Teaching physicians to assess suicidal youth presenting to the emergency department. Pediatric emergency care 2011. link 10 Lindfors PM, Meretoja OA, Luukkonen RA, Elovainio MJ, Leino TJ. Suicidality among Finnish anaesthesiologists. Acta anaesthesiologica Scandinavica 2009. link 11 Schmidt TA, Zechnich AD. Suicidal patients in the ED: ethical issues. Emergency medicine clinics of North America 1999. link70065-1) 12 Pfeffer CR. Assessment of suicidal children and adolescents. The Psychiatric clinics of North America 1989. link 13 Levitan H. Vicissitudes of the suicidal impulse in dreams. Suicide & life-threatening behavior 1984. link 14 Feinsilver DL. The suicidal patient: clinical and legal issues. Hospital practice (Office ed.) 1983. link

Deliberate self-cutting